<DOC>
	<DOCNO>NCT01854814</DOCNO>
	<brief_summary>The study evaluate effect Mycophenolate Mofetil compare losartan alone time double serum creatinine onset end stage renal disease patient advance IgA nephropathy treat maximal tolerated daily dose losartan.The study also assess effect MMF compare losartan alone change urine albumin excretion change estimate glomerular filtration rate .</brief_summary>
	<brief_title>The Effects Mycophenolate Mofetil ( MMF ) Renal Outcomes Advanced Immunoglobulin A ( IgA ) Nephropathy Patients</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Glomerulonephritis , IGA</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>Biopsyproven primary IgA nephropathy urinary proteinuria excretion 1g/24 hour , subject must meet 2 follow criterion : 1. global glomerular sclerosis plus focal segmental glomerular sclerosis ratio â‰¥50 % 2. eGFR 3050 ml/min 3 . Hypertension ( blood pressure 140/90 mmHg take antihypertensive drug ) 1 . Secondary IgA nephropathy 2 . Familial IgA nephropathy 3 . Concomitant disease : cancer , infection , diabetes mellitus , connective tissue disease , abnormal liver function 4 . Pregnancy breast 5 . Inability comply study followup procedure</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>